Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 3 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 6 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
Moderna’s flu-COVID combo shot hits goal in late-stage trial - The Boston Globe
The Boston Globe· 6 days agoModerna said its combination flu and Covid shot met the goals of a pivotal late-stage trial,...
Pentagon defends anti-vaccine disinformation program in the Philippines
Task & Purpose· 1 day agoThe Department of Defense is standing by a major disinformation campaign it led that worked to...
Results are looking promising for a combined COVID and flu vaccine—here's how it could benefit...
Medical Xpress· 1 day agoCombination vaccines have been successfully used for several decades in Australia and around the...
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
WFMZ Eastern Pennsylvania and Western New Jersey· 2 days agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
Moderna says combination flu, COVID shot succeeds in study
BioPharma Dive via Yahoo Finance· 6 days agoModerna’s RSV shot, dubbed Mresvia, was cleared by the FDA late last month for use in older adults....
Combined flu and Covid jab produces ‘higher immune response’ than separate injections
Daily Telegraph· 6 days agoNew vaccine from Moderna matched or bettered antibody production compared to current influenza jabs,...
Moderna’s flu-COVID combo shot hits goal in late-stage trial
Detroit News· 6 days agoModerna Inc. said its combination flu and COVID shot met the goals of a pivotal late-stage trial,...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 5 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...